Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.14740/jocmr4201

http://scihub22266oqcxt.onion/10.14740/jocmr4201
suck pdf from google scholar
32587649!7295552!32587649
unlimited free pdf from europmc32587649    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid32587649
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Medical Management of COVID-19: Evidence and Experience #MMPMID32587649
  • Bose S; Adapa S; Aeddula NR; Roy S; Nandikanti D; Vupadhyayula PM; Naramala S; Gayam V; Muppidi V; Konala VM
  • J Clin Med Res 2020[Jun]; 12 (6): 329-343 PMID32587649show ga
  • Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and this infectious disease is termed COVID-19 in short. On a global scale, as of June 1, 2020, the World Health Organization (WHO) published statistics of 6,057,853 infected patients and 371,166 deaths worldwide. Despite reported observational data about the experimental use of certain drugs, there is no conclusively proven curative therapy for COVID-19 as of now; however, remdesivir received emergency use authorization (EUA) by the Food and Drug Administration (FDA) recently for use in patients hospitalized with COVID-19. There are several ongoing clinical trials related to the pharmacological choices of therapy for COVID-19 patients; however, drug trials related to observational studies so far have yielded mixed results and therefore have created a sense of confusion among healthcare professionals (HCPs). In this review article, we seek to collate and provide a summary of treatment strategies for COVID-19 patients with a variable degree of illness and discuss pharmacologic and other therapies intended to be used either as experimental medicine/therapy or as part of supportive care in complicated cases of COVID-19.
  • ä


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    329 6.12 2020